Article Versions Notes

Lundberg AS, Geuijen CAW, Hill S, Lammerts van Bueren JJ, Fumagalli A, de Kruif J, Silverman PB, Tabernero J. Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications. Cancers. 2025; 17(10):1665. https://doi.org/10.3390/cancers17101665

Lundberg, Ante S., Cecile A. W. Geuijen, Sally Hill, Jeroen J. Lammerts van Bueren, Arianna Fumagalli, John de Kruif, Peter B. Silverman, and Josep Tabernero. 2025. "Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications" Cancers 17, no. 10: 1665. https://doi.org/10.3390/cancers17101665

Lundberg, A. S., Geuijen, C. A. W., Hill, S., Lammerts van Bueren, J. J., Fumagalli, A., de Kruif, J., Silverman, P. B., & Tabernero, J. (2025). Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications. Cancers, 17(10), 1665. https://doi.org/10.3390/cancers17101665